SONA DE is an experienced trial lawyer who has led numerous victories in both bench and jury trials and on appeal before the Federal Circuit. She has also handled multi-party litigations, argued before the Multidistrict Litigation Panel, represented clients in arbitration, and defended witnesses overseas under the Hague Convention. Her work spans a wide range of technology sectors, with a focus on biologics, Hatch-Waxman litigation and medical devices/med-tech, and further includes cases involving crop science, chemicals, computer chips, telephonic systems and consumer products. Her prior work experience in the pharmaceutical industry enables Sona to represent clients on various patent issues with an understanding of how companies operate with an eye towards their business needs.
Sona has been involved in several high-profile cases. She represented Bayer HealthCare in its jury trial win against Baxalta’s flagship hemophilia product that led to the largest damages verdict from a Delaware jury for a biologic and won LMG Life Sciences’ 2019 “Patent Impact Case of the Year”. She represented Amgen/Immunex in its trial win against Sandoz’s biosimilar of Enbrel®. She was featured as American Lawyer’s “Litigator of the Week” and received the Financial Times’ highest ranking for her innovative strategies and success in the landmark Therasense case that created a new legal standard for the inequitable conduct doctrine. She was profiled by InsideCounsel for helping Bayer HealthCare win its Hatch-Waxman trial on a formulation patent based on the doctrine of equivalents and received LMG Life Sciences 2013 “Hatch-Waxman Impact Case of the Year” award.
Sona has been recommended in Healthcare: Life Sciences in The Legal 500 US; is recognized for her patent litigation work by the IAM Patent 1000; is recognized among “The Top Women Attorneys in the New York Metro Area”; was shortlisted for LMG Life Sciences’ 2017 “General Patent Litigator of the Year” in New York and named in the 2019 LMG Life Sciences guide for intellectual property; and has received the “In Motion Commitment to Justice Award.”